Trials / Completed
CompletedNCT04510350
Investigation of Novel Immunological Biomarkers by Mass Cytometry in Patients With Early Multiple Sclerosis (CISCO)
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 90 (actual)
- Sponsor
- Rennes University Hospital · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Accepted
Summary
The objective of CISCO is therefore to identify prognostic biomarkers of MS activity in early-stage patients.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | Biomarkers analysis | Genetic analysis of regions of interest |
Timeline
- Start date
- 2020-02-19
- Primary completion
- 2022-03-02
- Completion
- 2022-03-02
- First posted
- 2020-08-12
- Last updated
- 2022-03-03
Locations
1 site across 1 country: France
Source: ClinicalTrials.gov record NCT04510350. Inclusion in this directory is not an endorsement.